Article
Prevention of skin carcinogenesis by the β-blocker carvedilol.
Cancer prevention research (Philadelphia, Pa.) - 1 Jan 2015
Chang Andy, Yeung Steven, Thakkar Arvind, Huang Kevin M, Liu Mandy M, Kanassatega Rhye-Samuel, Parsa Cyrus, Orlando Robert, Jackson Edwin K, Andresen Bradley T, Huang Ying
Abstract excerpt
The stress-related catecholamine hormones and the α- and β-adrenergic receptors (α- and β-AR) may affect carcinogenesis. The β-AR GRK/β-arrestin biased agonist carvedilol can induce β-AR-mediated transactivation of the EGFR. The initial purpose of this study was to determine whether carvedilol, through activation of EGFR, can promote cancer. Carvedilol failed to promote anchorage-independent growth of JB6 P(+)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
